Celestovet 5 ml
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
Disponible à partir de 31-12-2029
Composition
1 ml suspension for injection contains: Betamethasone 12.0 mg, Betamethasone phosphate disodium 3.948 mg
Indication
Celestovet acts palliative (supportive) in the treatment of the following diseases:
Horse: non-infectious inflammation of the joints
Dog : non-infectious inflammation of joints, tendon sheaths and bursae and other non-infectious inflammatory diseases of the musculoskeletal system.
Dosage and administration
For intra-articular and intramuscular administration.
- Horses: 34.6 to 69.2 mg betamethasone per animal, corresponding to 2.5 to 5 ml per animal. Via intraarticular.
- Dogs: 0.18 to 0.35 mg betamethasone / kg body weight corresponding to 0.013 to 0.025 ml per kg of body weight. Via intramuscular or intra-articular.
Depending on the severity of the disease, a treatment with the same dose cen be done 3 - 5 weeks after the first injection.
Special precautions for storage
Store in a refrigerator (+2 ° C to +8 ° C). Shake well before use! Used immediately after opening.